NXTC earnings at a glance
NextCure, Inc. (NXTC) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of -$0.90, compared with -$3.22 in the same quarter last year (+72%). Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±4.3% on average; after the most recent report on Aug 6, 2026 it moved +4.5%. NXTC beat the consensus EPS estimate in 4 of its last 6 reported quarters. The share price of $4.70 sits in the middle of its 52-week range.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | $-1.84 | $-1.98 | +7.1% | +82.5% | +4.5% | earnings |
| Thu May 7, 2026 | Mar/2026 | $-1.87 | $-1.85 | -1.1% | -379.5% | -4.1% | earnings |
| Thu Mar 5, 2026 | 8K 2026-03-05 | $-0.81 | $-2.26 | +64.2% | — | -2.9% | earnings |
| Wed Nov 5, 2025 | Sep/2025 | $-3.22 | $-4.06 | +20.7% | — | +2.0% | earnings |
| Thu Aug 7, 2025 | Jun/2025 | $-11.29 | $-4.62 | -144.4% | — | -4.4% | earnings |
| Thu May 1, 2025 | Mar/2025 | $-0.39 | $-0.40 | +2.5% | — | -7.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-4.95 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-6.61 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.61 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.51 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.64 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.58 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-0.68 | — | — | — | — | financials |
| Thu Jun 30, 2022 | Jun 2022 | $-0.65 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Nov 4, 2026 | Sep/2026 | OTHER | -$0.90 | -$3.22 | +72.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-10M | — | $-9M | — | $-12M | — | $-12M | $-16M |
| Net income | — | — | $-9M | — | — | — | $-12M | $-15M |
| EPS (diluted) | $-1.87 | — | $-3.22 | — | $-4.70 | — | $-4.95 | $-6.61 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $26M | $7M | $5M | $22M | $28M | $28M | $21M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $32M | $44M | $33M | $40M | $59M | $72M | $79M | $90M |
| Total assets | $38M | $50M | $40M | $48M | $67M | $81M | $90M | $103M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $11M | $15M | $16M | $16M | $11M | $15M | $15M | $17M |
| Total equity | — | $35M | $24M | — | — | $65M | $76M | $85M |
Implied volatility — last 90 days
No IV snapshots yet for NXTC.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
NXTC earnings FAQ
When is NXTC's next earnings date?
NextCure, Inc. is expected to report on November 4, 2026.
How does NXTC stock usually react to earnings?
Across the last 6 reports the average next-day move was ±4.3%, up 2 times and down 4 times.
What EPS are analysts expecting from NextCure, Inc.?
The consensus estimate is -$0.90 per share, versus -$3.22 a year ago.